Objective: To assess knowledge and attitudes toward opioids and buprenorphine (BUP) of patients with cancer.
Design: Single-site, single-intervention telephone survey of patients under palliative care at the cancer center.
Outcomes: Forty percent of the participants recognized the word "buprenorphine," and 28 percent recognized BUP indication for addiction treatment.